681 related articles for article (PubMed ID: 34987749)
21. DOACs vs Vitamin K Antagonists During Cardiac Rhythm Device Surgery: A Multicenter Propensity-Matched Study.
Creta A; Ventrella N; Earley MJ; Finlay M; Sporton S; Maclean E; Kanthasamy V; Lemos Silva Di Nubila BC; Ricciardi D; Calabrese V; Picarelli F; Hunter RJ; Lambiase PD; Schilling RJ; Grigioni F; Monkhouse C; Muthumala A; Moore P; Providencia R; Chow A
JACC Clin Electrophysiol; 2024 Jan; 10(1):121-132. PubMed ID: 37897463
[TBL] [Abstract][Full Text] [Related]
22. Safety and efficacy of direct oral anticoagulants in patients with chronic thromboembolic pulmonary hypertension.
Benzidia I; Robitaille C; Abualsaud A; McDonald L; Lesenko L; Morin JF; Langleben D; Kahn SR; Hirsch A
Thromb Res; 2023 Sep; 229():139-145. PubMed ID: 37453256
[TBL] [Abstract][Full Text] [Related]
23. Anticoagulation for the long-term treatment of venous thromboembolism in patients with cancer.
Akl EA; Kahale L; Barba M; Neumann I; Labedi N; Terrenato I; Sperati F; Muti P; Schünemann H
Cochrane Database Syst Rev; 2014 Jul; (7):CD006650. PubMed ID: 25004410
[TBL] [Abstract][Full Text] [Related]
24. A Real-World Cost-Effectiveness Analysis of Rivaroxaban versus Vitamin K Antagonists for the Treatment of Symptomatic Venous Thromboembolism: Lessons from the REMOTEV Registry.
Kepka S; Cordeanu EM; Zarca K; Frantz AS; Ohlmann P; Andres E; Bilbault P; Durand-Zaleski I; Stephan D
Medicina (Kaunas); 2023 Jan; 59(1):. PubMed ID: 36676804
[No Abstract] [Full Text] [Related]
25. Direct Oral Anticoagulants in Patients With Inherited Thrombophilia and Venous Thromboembolism: A Prospective Cohort Study.
Campello E; Spiezia L; Simion C; Tormene D; Camporese G; Dalla Valle F; Poretto A; Bulato C; Gavasso S; Radu CM; Simioni P
J Am Heart Assoc; 2020 Dec; 9(23):e018917. PubMed ID: 33222589
[TBL] [Abstract][Full Text] [Related]
26. The Role of Direct Oral Anticoagulants in the Treatment of Cancer-Associated Venous Thromboembolism: Review by Middle East and North African Experts.
Bazarbashi S; El Zawahry HM; Owaidah T; AlBader MA; Warsi A; Marashi M; Dawoud E; Jaafar H; Sholkamy SM; Haddad F; Cohen AT
J Blood Med; 2024; 15():171-189. PubMed ID: 38686358
[TBL] [Abstract][Full Text] [Related]
27. Effectiveness and Safety of Oral Anticoagulants in the Treatment of Acute Venous Thromboembolism: A Nationwide Comparative Cohort Study in France.
Bertoletti L; Gusto G; Khachatryan A; Quignot N; Chaves J; Moniot A; Mokgokong R
Thromb Haemost; 2022 Aug; 122(8):1384-1396. PubMed ID: 34983073
[TBL] [Abstract][Full Text] [Related]
28. Comparative effectiveness of oral anticoagulants in venous thromboembolism: GARFIELD-VTE.
Bounameaux H; Haas S; Farjat AE; Ageno W; Weitz JI; Goldhaber SZ; Turpie AGG; Goto S; Angchaisuksiri P; Nielsen JD; Kayani G; Schellong S; Mantovani LG; Prandoni P; Kakkar AK
Thromb Res; 2020 Jul; 191():103-112. PubMed ID: 32422442
[TBL] [Abstract][Full Text] [Related]
29. Differential benefit risk assessment of DOACs in the treatment of venous thromboembolism: focus on dabigatran.
Leung TS; Law EH
Drug Des Devel Ther; 2015; 9():3557-69. PubMed ID: 26185422
[TBL] [Abstract][Full Text] [Related]
30. Abnormal vaginal bleeding in women of reproductive age treated with edoxaban or warfarin for venous thromboembolism: a post hoc analysis of the Hokusai-VTE study.
Scheres L; Brekelmans M; Ageno W; Ay C; Büller HR; Eichinger S; Hutten BA; Klok FA; Middeldorp S; Schreiber K; Stach K; Blondon M; Delluc A
BJOG; 2018 Nov; 125(12):1581-1589. PubMed ID: 29940089
[TBL] [Abstract][Full Text] [Related]
31. Anticoagulation Treatment and Outcomes of Venous Thromboembolism by Weight and Body Mass Index: Insights From the Veterans Health Administration.
Perino AC; Fan J; Schmitt S; Guo JD; Hlavacek P; Din N; Kothari M; Pundi K; Russ C; Emir B; Turakhia MP
Circ Cardiovasc Qual Outcomes; 2021 Nov; 14(11):e008005. PubMed ID: 34724801
[TBL] [Abstract][Full Text] [Related]
32. Assessment of quality of life, satisfaction with anticoagulation therapy, and adherence to treatment in patients receiving long-course vitamin K antagonists or direct oral anticoagulants for venous thromboembolism.
Keita I; Aubin-Auger I; Lalanne C; Aubert JP; Chassany O; Duracinsky M; Mahé I
Patient Prefer Adherence; 2017; 11():1625-1634. PubMed ID: 29026288
[TBL] [Abstract][Full Text] [Related]
33. Comparing U.S. and Canadian treatment patterns on venous thromboembolism outcomes in the GARFIELD-VTE registry.
Chen AC; Rao AS; Oropallo A; Goldhaber SZ; Fluharty ME; Maheshwari U; Carrier M; Turpie AGG; Pieper K; Kayani G; Kakkar AK;
Thromb Res; 2023 Dec; 232():123-132. PubMed ID: 37976732
[TBL] [Abstract][Full Text] [Related]
34. Vitamin K antagonists versus low-molecular-weight heparin for the long term treatment of symptomatic venous thromboembolism.
Andras A; Sala Tenna A; Stewart M
Cochrane Database Syst Rev; 2017 Jul; 7(7):CD002001. PubMed ID: 28737834
[TBL] [Abstract][Full Text] [Related]
35. The American College of Chest Physician score to assess the risk of bleeding during anticoagulation in patients with venous thromboembolism.
Palareti G; Antonucci E; Mastroiacovo D; Ageno W; Pengo V; Poli D; Testa S; Tosetto A; Prandoni P
J Thromb Haemost; 2018 Oct; 16(10):1994-2002. PubMed ID: 30059189
[TBL] [Abstract][Full Text] [Related]
36. Bleeding and thrombotic outcomes associated with postoperative use of direct oral anticoagulants after open peripheral artery bypass procedures.
Obi AT; Thompson JR; Beaulieu RJ; Sutzko DC; Osborne N; Albright J; Gallagher KA; Henke PK
J Vasc Surg; 2020 Dec; 72(6):1996-2005.e4. PubMed ID: 32278573
[TBL] [Abstract][Full Text] [Related]
37. Efficacy and safety of anticoagulant agents in patients with venous thromboembolism and cancer: A network meta-analysis.
Vedovati MC; Giustozzi M; Bonitta G; Agnelli G; Becattini C
Thromb Res; 2018 Oct; 170():175-180. PubMed ID: 30196195
[TBL] [Abstract][Full Text] [Related]
38. Decreased Bleeding Incidence with Direct Oral Anticoagulants Compared to Vitamin K Antagonist and Low-Molecular-Weight Heparin in Patients with Sickle Cell Disease and Venous Thromboembolism.
Patel A; Williams H; Baer MR; Zimrin AB; Law JY
Acta Haematol; 2019; 142(4):233-238. PubMed ID: 31108496
[TBL] [Abstract][Full Text] [Related]
39. The HAS-BLED Score Identifies Patients with Acute Venous Thromboembolism at High Risk of Major Bleeding Complications during the First Six Months of Anticoagulant Treatment.
Kooiman J; van Hagen N; Iglesias Del Sol A; Planken EV; Lip GY; van der Meer FJ; Cannegieter SC; Klok FA; Huisman MV
PLoS One; 2015; 10(4):e0122520. PubMed ID: 25905638
[TBL] [Abstract][Full Text] [Related]
40. Treatment of DVT: how long is enough and how do you predict recurrence.
Agnelli G; Becattini C
J Thromb Thrombolysis; 2008 Feb; 25(1):37-44. PubMed ID: 17906973
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
